Increased DNA adducts in Barrett's esophagus and reflux-related esophageal malignancies

Annals of Medicine

Volumn 34, Issue 7-8, 2002, Pages 565-570

  Salminen, Jukka T ^a   Rämö, O Juhani ^a   Ahotupa, Markku O ^b   Färkkilä, Martti A ^c   Salo, Jarmo A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b MCA Research Laboratory Ltd   (Finland)

^c NONE

Author keywords

Adenocarcinoma; Barrett's esophagus; DNA adducts; Esophagus

Indexed keywords

NUCLEOTIDE; PHOSPHORUS 32;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DNA DETERMINATION; DNA ISOLATION; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; PATHOGENESIS; PRECANCER; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH BIOPSY;

EID: 0036948952     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/078538902321117779     Document Type: Article

References (34)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9.
2. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104: 510-3.
3. Reed PI, Johnston BJ. The changing incidence of oesophageal cancer. Endoscopy 1993; 2: 606-8.
4. Sihvo EIT, Salminen JT, Rämö OJ, Salo JA. The epidemiology of oesophageal adenocarcinoma: Has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma? Scand J Gastroenterol 2000; 35: 1082-6.
5. Levine DS. Management of dysplasia in the columnar-lined esophagus. Gastroenterol Clin North Am 1997; 26: 613-34.
6. Nestmann ER, Bryant DW, Carr CJ. Toxicological significance of DNA adducts: summary of discussions with an expert panel. Regul Toxicol Pharmacol 1996; 24: 9-18.
7. Beach AC, Gupta RC. Human biomonitoring and the 32P-postlabeling assay. Carcinogenesis 1992; 13: 1053-74.
8. Kriek E, Rojas M, Alexandrov K, Bartsch H. Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mutat Res 1998; 400: 215-31.
9. Kure E, Ryberg D, Hewer A, Phillips DH, Skaug V, Baera R, et al. p53 mutations in lung tumors: relationship to gender and lung DNA adduct levels. Carcinogenesis 1996; 17: 2201-5.
10. Flamini G, Romano G, Curigliano G, Chiominto A, Capelli G, Boninsegna A, et al. 4-Aminobiphenyl-DNA adducts in laryngeal tissue and smoking habits: an immunohistochemical study. Carcinogenesis 1998; 19: 353-7.
11. Li D, Wang M, Dhingra K, Hittelman WN. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 1996; 56: 287-93.
12. Wang M, Abbruzzese JL, Friess H, Hittelman WN, Evans DB, Abbruzzese MC, et al. DNA adducts in human pancreatic tissues and their potential role in carcinogenesis. Cancer Res 1998; 58: 38-41.
13. Lee BM, Jang JJ, Kim HS. Benzo[a]pyrene diol-epoxide-I-DNA and oxidative DNA adducts associated with gastric adenocarcinoma. Cancer Lett 1998; 125: 61-8.
14. Poirier MC. DNA adducts as exposure biomarkers and indicators of cancer risk. Environ Health Perspect 1997; 105(Suppl 4): 907-12.
15. Bremner CG, Lynch VP, Ellis FH. Barrett's esophagus: Congenital or acquired? An experimental study of esophageal mucosal regeneration in the dog. Surgery 1978; 68: 209-16.
16. Salo JA, Kivilaakso EO, Kiviluoto TA, Virtanen IO. Cytokeratin profile suggests metaplastic epithelial transformation in Barrett's oesophagus. Ann Med 1996; 28: 305-9.
17. Gupta RC. Non-random binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci USA 1984; 81: 6943-7.
18. Hemminki K, Widlak P, Hou S-M. DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro. Carcinogenesis 1995; 16: 1661-4.
19. Umbenhauer D, Wild CP, Montesano R, Saffhill R, Boyle JM, Huh N, et al. O(6)-methyldeoxyguanosine in oesophageal DNA among individuals at high risk of oesophageal cancer. Int J Cancer 1985; 36: 661-5.
20. Lu SH, Ruggero M, Zhang MS., Feng L, Luo FJ., Chui SX, et al. Relevance of N-nitrosamines to esophageal cancer in China. J Cell Physiol 1986; (Suppl 4): 51-8.
21. Izzotti A, Balansky RM, Blagoeva PM, Mircheva ZI, Tulimiero L, Cartiglia C, et al. DNA alterations in rat organs after chronic exposure to cigarette smoke and/or ethanol ingestion. FASEB J 1998; 12: 753-8.
22. Singh P, Taylor RH, Colin-Jones DG. Simultaneous two level oesophageal pH monitoring in healthy controls and patients with oesophagitis: comparison between two positions. Gut 1994; 35: 304-8.
23. De Flora S, Izzotti A, Randerath K, Randerath E, Bartsch H, Nair J, et al. DNA adducts and chronic degenerative diseases. Pathogenetic relevance and implications in preventive medicine. Mutat Res 1996; 366: 197-238.
24. Siurala M, Lehtola J, Ihamäki T. Atrophic gastritis and its sequale. Results of 19-23 years' follow-up examinations. Scand J Gastroenterol 1974; 9: 441-6.
25. Gilat T, Fireman Z, Grossman A, Hacohen D, Kadish U, Ron E, et al. Colorectal cancer in patients with ulcerative colitis. Gastroenterology 1988; 94: 870-7.
26. Pera M, Trastek VF, Carpenter HA, Fernandez PL, Cardesa A, Mohr U, et al. Influence of pancreatic and biliary reflux on the development of esophageal carcinoma. Ann Thorac Surg 1993; 55: 1386-93.
27. Salminen JT, Tuominen JA, Rämö OJ, Färkkilä MA, Salo JA. Esophageal acid exposure in Barrett's esophagus: higher than in reflux esophagitis. Ann Med 1999; 31: 46-50.
28. Vaezi MF, Richter JE. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 1995; 117: 699-704.
29. Wetscher GJ, Hinder RA, Bagchi D, Hinder PR, Bagchi M, Perdikis G, et al. Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg 1995; 170: 552-6.
30. Salminen JT, Rämö OJ, Färkkilä MA, Salo JA. Endogenous radical scavengers in Barrett's esophagus. Gastroenterology 1998; 114: G1128(A).
31. Shimoda R, Nagashima M, Sakamoto M, Yamaguchi N, Hirohashi S, Yokota J, et al. Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis. Cancer Res 1994; 54: 3171-2.
32. Malins DC, Holmes EH, Polissar NL, Gunselman SJ. The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer 1993; 71: 3036-43.
33. Scates DK, Spigelman AD, Phillips RKS, Venitt S. The use of 32P-poslabelling in studies of the nature and origin of DNA adducts formed by bile from patients with familial adenomatous polyposis and from normal patients. Mutat Res 1997; 378: 113-25.
34. Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31.